Clinical Trial Update: Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluated once-daily tadalafil for 12 weeks in men with signs and symptoms of benign prostatic hyperplasia, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tadalafil (Cialis) (tadalafil)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-08-19